Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified
ICD-10 F13.259 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified.
F13.259 refers to a condition characterized by a dependence on sedative, hypnotic, or anxiolytic substances, accompanied by a psychotic disorder induced by these substances. Patients with this diagnosis often exhibit symptoms such as hallucinations, delusions, and disorganized thinking, which arise during periods of intoxication or withdrawal from these substances. The psychotic symptoms can significantly impair the individual's ability to function in daily life and may require immediate intervention. Dependence on these substances typically develops over time, often as a result of prolonged use for anxiety or sleep disorders. Treatment may involve a combination of detoxification, psychotherapy, and medication management to address both the substance dependence and the psychotic symptoms. Accurate diagnosis and coding are crucial for effective treatment planning and insurance reimbursement.
Detailed psychiatric evaluations, including history of substance use and mental health assessments.
Patients presenting with acute psychosis following sedative withdrawal or overdose.
Ensure clear documentation of the relationship between substance use and psychotic symptoms.
Comprehensive substance use history and treatment plans, including detoxification protocols.
Patients undergoing rehabilitation for sedative dependence with co-occurring psychotic symptoms.
Documenting the treatment approach and response to therapy is critical for accurate coding.
Used for follow-up visits for patients with substance use disorders and associated psychotic symptoms.
Document the patient's history, mental status examination, and treatment plan.
Psychiatrists should ensure comprehensive notes reflecting the complexity of the patient's condition.
F13.259 includes the presence of a psychotic disorder induced by sedative, hypnotic, or anxiolytic use, while F13.20 refers to uncomplicated dependence without psychotic features.
